| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/26/2011 | US20110123436 Dock-and-Lock (DNL) Complexes for Delivery of Interference RNA |
| 05/26/2011 | US20110123435 Compounds for inhibiting ksp kinesin activity |
| 05/26/2011 | DE102009054302A1 Chinazolinderivate Quinazoline derivatives |
| 05/26/2011 | CA2781066A1 Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use |
| 05/26/2011 | CA2780912A1 Use of macrocyclic lactone derivatives for the treatment of inflammatory disorders |
| 05/26/2011 | CA2780287A1 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
| 05/25/2011 | EP2325300A1 Desaturase genes and uses thereof |
| 05/25/2011 | EP2325205A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 05/25/2011 | EP2325203A2 Cadherin materials and methods |
| 05/25/2011 | EP2325193A2 Methods and compositions for therapeutic use of RNA interference |
| 05/25/2011 | EP2324861A1 In vivo use of water absorbent polymers |
| 05/25/2011 | EP2324851A1 Methods of administering anti-TNFalpha antibodies |
| 05/25/2011 | EP2324841A1 Use of a traditional chinese medicinal composition for preparing medicine for promoting bone marrow-derived mesenchymal stem cell survival in vivo and cardiac muscle differentiation |
| 05/25/2011 | EP2324839A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 05/25/2011 | EP2324834A2 Methods of Increasing Endogenous Erythropoietin (EPO) |
| 05/25/2011 | EP2324830A1 Process for the preparation of a monocyclic azole derivative that inhibits the interaction of ligands with rage |
| 05/25/2011 | EP2324825A1 Aryl ureas with angiogenesis inhibiting activity |
| 05/25/2011 | EP2324059A1 Anti-pamp therapeutic antibodies |
| 05/25/2011 | EP2324054A2 Phosphopeptides and use of the same |
| 05/25/2011 | EP2324033A1 Isosorbide nitrates having vasodilating activity |
| 05/25/2011 | EP2324005A1 Novel methylenedioxy phenolic compounds and their use to treat disease |
| 05/25/2011 | EP2324003A1 6-substituted isoflavonoid compounds and uses thereof |
| 05/25/2011 | EP2323993A2 2,6-diamino- pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors |
| 05/25/2011 | EP2323991A2 Chymase inhibitors |
| 05/25/2011 | EP2323977A1 Atorvastatin-aliskiren |
| 05/25/2011 | EP2323669A1 Arabinoxylans for modulating the barrier function of the intestinal surface |
| 05/25/2011 | EP2323659A1 Compounds useful as inhibitors of protein kinases |
| 05/25/2011 | EP2323648A2 Anti-arrhythmia agents, methods of their use, methods for their identification, and kits thereofre |
| 05/25/2011 | EP2323647A1 Long-term treatment of symptomatic heart failure |
| 05/25/2011 | EP2212297B1 Inhibitors of protein kinases |
| 05/25/2011 | EP2197860B1 New compounds as adenosine a1 receptor antagonists |
| 05/25/2011 | EP2021335B1 Heterocyclic compounds as inhibitors of c-fms kinase |
| 05/25/2011 | EP1951672B1 Potassium channel inhibitors |
| 05/25/2011 | EP1919304B1 Compositions and methods for improving functional vascular integrity, cellular survival and reducing apoptosis after an ischemic episode in the brain |
| 05/25/2011 | EP1894576B1 Novel triglyceride reducing agent |
| 05/25/2011 | EP1755620B1 Sulphated depolymerised exopolysaccharide derivatives, their preparation and uses |
| 05/25/2011 | EP1534296B1 Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| 05/25/2011 | EP1425035B1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 05/25/2011 | EP1349562B1 Inhibiting gs-fdh to modulate no bioactivity |
| 05/25/2011 | EP1317454B1 Caspase inhibitors and uses thereof |
| 05/25/2011 | CN1813886B Chinese medicine formulation for activating blood flow and removing blood stasis and stopping pain, and its preparing method |
| 05/25/2011 | CN102076688A Purine derivatives further comprising a mercapto-acylamino group as neutral endopeptidase inhibitors |
| 05/25/2011 | CN102076682A Five-membered ring compound |
| 05/25/2011 | CN102076680A Benzoimidazoles as prolyl hydroxylase inhibitors |
| 05/25/2011 | CN102076671A Triazole derivative or salt thereof |
| 05/25/2011 | CN102076667A Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives |
| 05/25/2011 | CN102076665A Organic compounds |
| 05/25/2011 | CN102076664A A process for producing lercanidipine HCL form v |
| 05/25/2011 | CN102076650A Carboxylic acid compound |
| 05/25/2011 | CN102076352A Fgf-9 and its use relating to blood vessels |
| 05/25/2011 | CN102076347A Pharmaceutical composition comprising extracts of huanglian and ku ding cha effective for lowering blood lipid levels |
| 05/25/2011 | CN102076338A Diaryl ureas for treating heart failure |
| 05/25/2011 | CN102076337A Use of dronedarone for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level due to dronedarone administration |
| 05/25/2011 | CN102070715A Human antibodies that bind human TNF alpha |
| 05/25/2011 | CN102070617A Candesartan cilexetil compound and novel preparation method thereof |
| 05/25/2011 | CN102070605A Imatinib mesylate polymorph and pharmaceutical composition |
| 05/25/2011 | CN102070595A Substituted benzoxanthone type compound and application thereof |
| 05/25/2011 | CN102068685A Terlipressin preparation and preparations method thereof |
| 05/25/2011 | CN102068657A Quality control method of venation relaxing pill as Chinese herbal preparation |
| 05/25/2011 | CN102068629A Medicinal hat for assisting in treating primary hypertension |
| 05/25/2011 | CN102068627A Quality control method for Chinese medicine preparation Xinnaojing tabelets |
| 05/25/2011 | CN102068605A Traditional Chinese medicine composition for treating hypertension |
| 05/25/2011 | CN102068600A Quality control method of venation relaxing and heart-nourishing pill as Chinese herbal preparation |
| 05/25/2011 | CN102068595A New application of Chinese medicinal composition to treatment of vascular dementia |
| 05/25/2011 | CN102068577A Traditional Chinese medicine (TCM) composition and application thereof |
| 05/25/2011 | CN102068576A Hemorrhoids paste |
| 05/25/2011 | CN102068530A Traditional Chinese medicine for preventing and treating vascular dementia |
| 05/25/2011 | CN102068520A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| 05/25/2011 | CN102068500A Traditional Chinese medicine for treatment of diabetic coronary heart disease |
| 05/25/2011 | CN102068491A Medicinal composition for treating coronary heart disease and angina |
| 05/25/2011 | CN102068490A Applications of compound salvia tablet in inhibiting smooth muscle cell proliferation and preventing and treating vessel restenosis |
| 05/25/2011 | CN102068488A Traditional Chinese medicinal composition and preparation method for granules thereof |
| 05/25/2011 | CN102068485A Preparation and application of high-efficiency and low-toxicity effective fraction for suppressing angiogenesis in silktree albizzia bark |
| 05/25/2011 | CN102068483A Persimmon leaf extract for improving brain ischemic tolerance |
| 05/25/2011 | CN102068481A Preparation and application of low-toxicity effective fraction for suppressing angiogenesis in cowherb seed |
| 05/25/2011 | CN102068478A Safflower injection and preparation method thereof |
| 05/25/2011 | CN102068472A Preparation method for traditional Chinese medicinal pubescent holly root injection |
| 05/25/2011 | CN102068450A Application of aucubin to preparation of anti-thrombosis medicament |
| 05/25/2011 | CN102068441A Compound preparation containing telmisartan and glimepiride |
| 05/25/2011 | CN102068440A Drug composition for treating cardio-cerebrovascular diseases and preparation method |
| 05/25/2011 | CN102068426A New application of Ginkgolide B derivative in medicament preparation |
| 05/25/2011 | CN102068419A Curcumin composition |
| 05/25/2011 | CN102068417A Oral drug transporting system |
| 05/25/2011 | CN102068408A Fasudil hydrochloride injection and preparation method thereof |
| 05/25/2011 | CN101843594B Alprostadil freeze-dried emulsion for injection and preparation method thereof |
| 05/25/2011 | CN101816746B Medicament for treating hypertension and preparation method thereof |
| 05/25/2011 | CN101721572B Traditional Chinese medicine compound preparation for treating hemorrhagic apoplexy, preparation method and application thereof |
| 05/25/2011 | CN101708284B Medicament for treating hemorrhoids |
| 05/25/2011 | CN101697977B Deproteinized calf blood extractive injection and preparation method thereof |
| 05/25/2011 | CN101690777B Formula of polygonatum chewable tablets and preparation method thereof |
| 05/25/2011 | CN101653499B New application of peony blood stasis removing preparation in preparing medicaments for preventing or treating diabetic complication |
| 05/25/2011 | CN101637452B Atorvastatin calcium dried suspension and preparation method thereof |
| 05/25/2011 | CN101579400B Preparing method of preparation for preventing and treating cardiovascular and cerebrovascular diseases |
| 05/25/2011 | CN101554443B Traditional Chinese medicine for treating angina |
| 05/25/2011 | CN101543553B Traditional Chinese medicine composition for regulating qi-flowing and relieving chest stuffiness and pain |
| 05/25/2011 | CN101475526B Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 05/25/2011 | CN101444629B Non-injection gene therapy medicine and medicine box thereof |
| 05/25/2011 | CN101433586B Medicament for treating ischemic cerebrovascular disease and preparation method thereof |
| 05/25/2011 | CN101401789B Cordyceps sinensis polysaccharide liposome medicament and preparation thereof |
| 05/25/2011 | CN101317615B Silver-thorn tea beverage and preparation method thereof |